The impact of hemoglobin levels on patient and graft survival in renal transplant recipients

Transplantation

Volumn 86, Issue 4, 2008, Pages 564-570

  Moore, Jason ^a   He, Xiang ^b   Cockwell, Paul ^a   Little, Mark A ^a   Johnston, Atholl ^b   Borrows, Richard ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Anemia; Hemoglobin; Kidney transplantation

Indexed keywords

HEMOGLOBIN; SERUM ALBUMIN; UREA;

ADULT; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; CAUSE OF DEATH; GLOMERULUS FILTRATION RATE; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; KIDNEY TRANSPLANTATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SURVIVAL RATE;

ADULT; BODY MASS INDEX; CAUSE OF DEATH; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HEMOGLOBINS; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 52449086949     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318181e276     Document Type: Article

References (39)

1. Vanrenterghem Y, Ponticelli C, Morales JM, et al. Prevalence and management of anemia in renal transplant recipients: A European survey. Am J Transplant 2003; 3: 835.
2. Imoagene-Oyedeji AE, Rosas SE, Doyle AM, et al. Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: Risk factors and implications for mortality. J Am Soc Nephrol 2006; 17: 3240.
3. Molnar MZ, Czira M, Ambrus C, et al. Anaemia is associated with mortality in kidney-transplanted patients - A prospective cohort study. Am J Transplant 2007; 7: 818.
4. Yorgin PD, Scandling JD, Belson A, et al. Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem? Am J Transplant 2002; 2: 429.
5. Shah N, Al-Khoury S, Afzali B, et al. Posttransplantation anemia in adult renal allograft recipients: Prevalence and predictors. Transplantation 2006; 81: 1112.
6. Winkelmayer WC, Kewalramani R, Rutstein M, et al. Pharmacoepide-miology of anemia in kidney transplant recipients. J Am Soc Nephrol 2004; 15: 1347.
7. Turkowski-Duhem A,KamarN,CointaultO, et al. Predictive factors of anemia within the first year post renal transplant. Transplantation 2005; 80: 903.
8. Rigatto C, Parfrey P, Foley R, et al. Congestive heart failure in renal transplant recipients: Risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 2002; 13: 1084.
9. Heinze G, Mitterbauer C, Regele H, et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006; 17: 889.
10. Winkelmayer WC, Chandraker A, Alan Brookhart M, et al. A prospective study of anaemia and long-term outcomes in kidney transplant recipients. Nephrol Dial Transplant 2006; 21: 3559.
11. Ponticelli C, Villa M. Role of anaemia in cardiovascular mortality and morbidity in transplant patients. Nephrol Dial Transplant 2002; 17(suppl 1): 41.
12. Weir MR. Is anemia a predictor for mortality and loss of graft function in kidney transplant recipients? Am J Transplant 2007; 7: 731.
13. Lentine KL, Schnitzler MA, Abbott KC, et al. De novo congestive heart failure after kidney transplantation: A common condition with poor prognostic implications. Am J Kidney Dis 2005; 46: 720.
14. Abbott KC, Yuan CM, Taylor AJ, et al. Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol 2003; 14: 2358.
15. Dooldeniya MD, Dupont PJ, He X, et al. Renal transplantationin Indo-Asian patients in the UK. Am J Transplant 2006; 6: 761.
16. He X, Johnston A. Risk factors for allograft failure in United Kingdom renal transplant recipients treated with cyclosporine A. Transplantation 2005; 79: 953.
17. He X, Johnston A. Early acute rejection does not affect chronic allograft ne-phropathy and death censored graft failure. Transplant Proc 2004; 36: 2993.
18. The LOTESS study, study plan, renal transplant recipients. Norvartis, UK, 1995.
19. Wu C, Evans I, Joseph R, et al. Comorbid conditions in kidney transplantation: Association with graft and patient survival. J Am Soc Nephrol 2005; 16: 3437.
20. Levey AS, Greene T, Kusek JW, et al. A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol 2000; 11: A0828.
21. Ansell D, Udayaraj UP, Steenkamp R, et al. Chronic renal failure in kidney transplant recipients. Do they receive optimum care?: Data from the UK renal registry. Am J Transplant 2007; 7: 1167.
22. Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085.
23. Drüeke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071.
24. Silverberg DS, Wexler D, Iaina A, et al. The interaction between heart failure and other heart diseases, renal failure, and anemia. Semin Nephrol 2006; 26: 296.
25. Gouva C, Nikolopoulos P, Ioannidis JP, et al. Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial. Kidney Int 2004; 66: 753.
26. Fishbane S, Berns JS. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int 2005; 68: 1337.
27. Hariharan S, McBride MA, Cheirkh WS, et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62: 311.
28. Fellström B, Jardine AG, Soveri I, et al. Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation. Am J Transplant 2005; 5: 1986.
29. Woo YM, Jardine AG, Clark AF, et al. Early graft function and patient survival following cadaveric renal transplantation. Kidney Int 1999; 55: 692.
30. Jassal SV, Schaubel DE, Fenton SS. Baseline comorbidity in kidney transplant recipients: A comparison of comorbidity indices. Am J Kidney Dis 2005; 46: 136.
31. Guijarro C, Massy Z, Wiederkehr MR, et al. Serum albumin and mortality after renal transplantation. Am J Kidney Dis 1996; 27: 117.
32. Becker BN, Becker YT, Heisey DM, et al. The impact of hypoalbumin-emia in kidney-pancreas transplant recipients. Transplantation 1999; 68: 72.
33. Kalantar-Zadeh K. Recent advances in understanding the malnutrition-inflammation- cachexia syndrome in chronic kidney disease patients: What is next? Semin Dial 2005; 18: 365.
34. Massy ZA, Guijarro C, Wiederkehr MR, et al. Chronic renal allograft rejection: Immunological and nonimmunological risk factors. Kidney Int 1996; 49: 518.
35. Lietz K, Lewandowski Z, Lao M, et al. Pretransplant and early post-transplant predictors of chronic allograft nephropathy in cadaveric kidney allograft - A single centre analysis of 1112 cases. Transpl Int 2004; 17: 78.
36. Bosma RJ, Doorenbos CR, Stegeman CA, et al. Predictive performance of renal function equationsinrenal transplant recipients:Ananalysis of patient factors in bias. Am J Transplant 2005; 5: 2193.
37. Opelz G, Zeier M, Laux G, et al. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: A collaborative transplant study report. J Am Soc Nephrol 2006; 17: 3257.
38. Knoll G, Muirhead N, Trpeski L, et al. Patient survival following renal transplant failure in Canada. Am J Transplant 2005; 5: 1719.
39. Gill JS, Abichandani R, Kausz AT, et al. Mortality after kidney transplant failure: The impactofnon-immunologic factors. Kidney Int 2002; 62: 1875.